Press releases
-
-
-
-
-
-
Internal link ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement
-
-
-
-
-
-
Internal link ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event
-
-
Internal link ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026
-
-
-
Internal link ProQR Announces Planned Changes to Board Composition
-
Internal link ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook
-
Internal link ProQR Therapeutics Announces $8.1 Million in New Funding from Rett Syndrome Research Trust to Expand RNA Editing Collaboration
-
-
-
-
Internal link ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement
-
Internal link ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement
-